ViaLase^®
News

Check back here for the latest updates on our research and clinical studies, as well as industry coverage about the ViaLuxe^™ Laser System.

1 2 Next »

December 3, 2025 | Press Release

ViaLase Announces First Patient Treated in IDE Clinical Trial Evaluating Its Femtosecond Laser Trabeculotomy for Open-Angle Glaucoma

Read More

July 8, 2025 | Press Release

ViaLase Announces Strategic Leadership Transitions to Support Commercial Growth

Read More

July 30, 2024 | Press Release

ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase® Laser

Read More

April 1, 2024 | Press Release

ViaLase Closes $40 million Series C Financing to Advance First Femtosecond Laser for the Treatment of Glaucoma

Read More

May 30, 2023 | Press Release

ViaLase to Present Clinical Data at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Read More

April 18, 2023 | Press Release

ViaLase to Present New Scientific Data at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Read More

Sign up for our newsletter below and be sure to follow us on social media.

URL

This field is for validation purposes and should be left unchanged.

Name

First Last

Email